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Background: The Wnts are secreted proteins that play important roles in skeletal myogenesis, muscle fiber type
diversification, neuromuscular junction formation and muscle stem cell function. How Wnt proteins orchestrate
such diverse activities remains poorly understood. Canonical Wnt signaling stabilizes β-catenin, which subsequently
translocate to the nucleus to activate the transcription of TCF/LEF family genes.
Methods: We employed TCF-reporter mice and performed analysis of embryos and of muscle groups. We further
isolated fetal myoblasts and performed cell and molecular analyses.
Results: We found that canonical Wnt signaling is strongly activated during fetal myogenesis and weakly activated
in adult muscles limited to the slow myofibers. Muscle-specific transgenic expression of a stabilized
β-catenin protein led to increased oxidative myofibers and reduced muscle mass, suggesting that canonical Wnt
signaling promotes slow fiber types and inhibits myogenesis. By TCF-luciferase reporter assay, we identified Wnt-1
and Wnt-3a as potent activators of canonical Wnt signaling in myogenic progenitors. Consistent with in vivo data,
constitutive overexpression of Wnt-1 or Wnt-3a inhibited the proliferation of both C2C12 and primary myoblasts.
Surprisingly, Wnt-1 and Wnt-3a overexpression up-regulated BMP-4, and inhibition of BMP-4 by shRNA or
recombinant Noggin protein rescued the myogenic inhibitory effect of Wnt-1 and Wnt-3a. Importantly, Wnt-3a or
BMP-4 recombinant proteins promoted slow myosin heavy chain expression during myogenic differentiation of
fetal myoblasts.
Conclusions: These results demonstrate a novel interaction between canonical Wnt and BMP signaling that
induces myogenic differentiation towards slow muscle phenotype.
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specificationBackground
Skeletal muscles of the trunk and limb, except for some
craniofacial and esophageal muscles, are derived from so-
mites during embryonic development [1-3]. Specification
of somitic cells into myogenic lineages is regulated by
positive and negative signals from the surrounding tissues.
Wnt signaling induced by Wnt-1, -3a, -4, -6, -7a and 11
from dorsal neural tube or ectoderm is critical for the in-
duction, initiation and progression of myogenesis in the
presomitic mesoderm and early somites (Reviewed in
[4,5]). Within the embryonic myogenic progenitors, Wnt
also regulate the expression of Pax3/7, MyoD and Myf5,* Correspondence: mrudnicki@ohri.ca
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reproduction in any medium, provided the orkey transcription factors involved in myogenesis [6-10].
Importantly, genetic knockout studies have clearly dem-
onstrated the requirement of several Wnt molecules and
β-catenin in the normal development of skeletal muscles
[11,12]. These diverse functions of Wnt are mediated by
both a canonical signaling pathway that requires sta-
bilization and nuclear translocation of β-catenin, and non-
canonical pathway that is independent of β-catenin [5].
Therefore, canonical and non-canonical Wnt signaling
pathways play multiple essential roles in embryonic
myogenesis.
Wnt signaling is also involved in the regulation of post-
natal satellite cell function and skeletal muscle rege-
neration. Satellite cells are muscle resident stem cells
responsible for postnatal regeneration of injured muscles.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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muscle resident CD45+ stem cells to undergo myogenic
specification and differentiation [13]. Wnt-7a also acts
through the non-canonical Wnt signaling pathway to
stimulate the symmetric expansion of satellite cells and
promote skeletal muscle hypertrophy [14,15]. Similarly,
canonical Wnt activation was shown to induce satellite
cell proliferation during skeletal muscle regeneration [16].
However, contradictory results showing that activation of
canonical Wnt signaling is necessary to counteract Notch
signaling to induce myogenic differentiation were also
reported [17]. Furthermore, in the aged niche, elevated
systemic Wnt molecules impede myogenic differentiation
and facilitate satellite cell fate conversion to fibroblastic
cell lineages [18].
Adult skeletal muscles contain heterogeneous types of
muscle fibers that can be broadly divided into slow- and
fast-twitch myofibers [19]. In the limb muscles, the slow-
twitch myofibers express type I myosin heavy chain
(MyHC), while the fast-twitch myofibers express type IIa,
IIx and IIb MyHC isoforms [19]. During early stages
of myofiber generation in chicks, Wnt-11 promotes fast
myofiber formation, whereas Wnt-5 enhances slow myo-
fiber generation [20]. Wnt-4 similarly stimulated fast
myofiber formation in chicks [21]. Activation of β-catenin
induced myofiber hypertrophy followed by degeneration
of fast myofibers in zebrafish [22]. In mice, depletion of
β-catenin during myogenesis in Pax7-lineage cells led to
reduced slow myofibers and overall reduction of muscle
mass [23]. Interestingly, expression of stabilized β-catenin
in Pax7 lineage cells also led to reduced myogenesis but
increased slow myofibers [23]. These studies suggest that
Wnt signaling plays diverse roles in regulating slow- ver-
sus fast-twitch myofiber formation during development.
However, embryonic lethality of β-catenin deficient mice
or over-expressing mice precludes analysis of Wnt signa-
ling in postnatal muscles. In addition, how canonical Wnt
signaling regulates myofiber types has remained unclear.
Myofibers in postnatal skeletal muscles retain an adap-
tive capacity to switch between slow- and fast-twitch
properties that largely depend on motoneuron activity
[19]. Wnt signaling also regulates the establishment and
maintenance of neuromuscular junctions that connect
motor neurons and myofibers. In Drosophila and mice,
Wnt secreted by presynaptic motoneurons interact with
Agrin-MusK to induce assembly of postsynaptic endplates
(Reviewed in [24]). There is evidence that neuromuscular
junctions are phenotypically and functionally distinct in
fast and slow muscles [25,26]. Whether Wnt signaling is
differentially activated in slow and fast myofibers is com-
pletely unknown.
In this study, we used transgenic Wnt-reporter mice
and mice with constitutively activated canonical Wnt
signaling specifically within skeletal muscle to investigatethe function of canonical Wnt signaling in muscle. We
found that Wnt signaling is highly activated in prenatal
muscle and rapidly declines in postnatal muscle, with
some residual activation limited to the slow myofibers.
Interestingly, Wnt signaling is highly activated proximal
to motor endplates of slow myofibers. Wnt activation
induced by stabilized β-catenin inhibits muscle differen-
tiation and promotes slow muscle determination. At the
molecular level, canonical Wnt signaling induces BMP-4
, which promotes expression of slow MyHC. These novel
results demonstrate that interplay between Wnt and




Wnts cDNA subcloned from pLNCX-HA-Wnt constructs
(kindly gifted from Dr. Jan Kitajewski) to pHAN-puro
retrovirus vector by PCR [27,28]. Wnt-10b and TCF-4B
cDNA were obtained from Thermo Fisher Scientific Open
Biosystems (Waltham, MA, USA). Super TOPFlash was
kindly gifted from Dr. Moon [29]. The mouse BMP-4
shRNA pLKO.1-puro (RMM3981-9595140) was obtained
from Openbiosystems. Scramble shRNA pLKO.1-puro
(Addgene Plasmid #1864), MD2.G (Addgene Plasmid
#12259) and psPAX2 (Addgene Plasmid #12260) were
obtained from Addgene (Cambridge, MA, USA).
C2C12 myoblasts, single myofibers and isolation of
primary myoblasts
C2C12 cells are purchased from American Type Culture
Collection (ATCC) (Manassas, VA, USA) and cultured in
DMEM with 10% FBS and antibiotics. Cells are induced
to differentiation upon 80% confluence by serum with-
drawal (DMEM with 2% horse serum). Primary myoblasts
were isolated from the hind limb of two- to three–month-
old wild type mice as previously described [27]. Single
myofibers were isolated from flexor digitorum longus
(EDL) muscle by collagenase digestion. The single fibers
were immediately fixed in 4% paraformaldehyde (PFA),
permeabilized by Triton-X100, stained with primary anti-
bodies for β-gal (Life Technologies, Carlsbad, CA, USA),
MyHC (MF-20, Developmental Studies Hybridoma Bank
[DSHB], Iowa, Iowa, USA), slow MyHC (DSHB) and
FITC-conjugated α-bungarotoxin (BTX) (Sigma-Aldrich,
St. Louis, MO, USA). Nuclei were counter stained with
4',6-diamidino-2-phenylindole (DAPI).
Fetal myoblasts were prepared from the legs of Myf5-
Cre/ROSA26-YFP embryos at E14.5. The legs are
minced and digested by collagenase, dispase and DNaseI,
as previously described for satellite cells isolation [30].
After collagenase procedure, collected cells were stained
by alpha7-integrin antibody and anti-mouse IgG1-
Alexa648. Fetal myoblast were isolated by MoFlo (Dako,
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magnetic-antibody cell sorting (MACS) (Miltenyi Biotec,
Bergish Gladbach, Germany). The isolated cells were incu-
bated in culture dishes at 37°C for one hour to remove ad-
herent cells, and the nonadherent cells were collected.
The isolated fetal myoblasts cultured in DMEM/F10
medium with 20% FBS and bFGF.
Retrovirus and lentivirus infection
To prepare ecotropic retrovirus, Phoenix-eco packaging
(kindly gifted from Dr. Gally Nolan) cells were trans-
fected with retrovirus vectors using GeneJuice (Novagen
EMD Chemicals, Madison, WI, USA). Viral supernatants
were harvested 30 hours post transfection and used to
infect C2C12 cells in the presence of polybrene (Sigma,
8 mg/ml) for 12 hours. Infected C2C12 cells were then
washed twice with phosphate-buffered saline (PBS),
maintained in growth media and were selected 24 hours
post-infection with puromycin (1.5 micro g/ml, Sigma).
Lentivirus was packaged in 293T cells (ATCC CRL-
11268) transfected with the mouse BMP-4 or scramble
shRNA pLKO.1-puro plasmids in addition to the pMD2.
G and psPAX2 plasmids. Lentivirus was concentrated by
ultracentrifuge and resolved in PBS(−) for virus infec-
tion. Infected C2C12 and primary myoblast cells were
then washed twice with PBS, and maintained in growth
media.
Gene expression analysis
Total RNAs were prepared from C2C12 and myoblast
cells by TRIzol (Life Technologies). RNA samples were
reverse transcribed using random hexamer and oligo dT
mixed primers with SuperScriptII enzyme (Life Techono-
logies) according to the manufacturer’s instructions. Re-
verse transcription reactions were diluted (1:10) with 10
mM Tris, pH 8.0, yielding master samples of reverse-
transcribed products. Real-time PCR reactions are previ-
ously described [27]. Real-time data were gathered using a
system (MX4000; Agilent Technologies, Santa Clara, CA,
USA) over 40 cycles (30 s at 90°C, 60 s at 58°C and 30 s at
72°C) followed by a denaturation curve from 54°C to 94°C
in 30-s increments of 0.5°C to ensure amplification specifi-
city. Threshold cycle (Ct) values were calculated with the
MX4000 software (Agilent Technologies, Santa Clara, CA,
USA) by using moving window aver-aging and an adap-
tive baseline. Fold changes, other calculations and chart
plotting were performed in Microsoft Excel (Redmond,
WA, USA). The sequence of PCR primers is listed in
Additional file 1: Table S1.
Animal care
Myf5-Cre [31] heterozygous mice were bred with
ROSA26-YFP [32]. TCF-lacZ [33] and Ctnn1 exon3 floxed
[34] mice were previously described. All mice are main-tained inside a barrier facility, and experiments were per-
formed in accordance with the University of Ottawa regu-
lations for animal care and handling.
Immunofluorescence staining
C2C12 cells were incubated at 37°C for two hours with
10 μM BrdU, then washed with PBS(−) and fixed with
2% PFA/PBS. The fixed cells were stained with DAPI for
15 minutes at room temperature, washed with PBS(−),
and refixed with 2% PFA for 5 minutes at room tem-
perature. The refixed cells were treated with 2N HCl for
20 minutes at room temperature (RT), neutralized by
washing with 0.1 M borate buffer pH 8.5. The cells were
permeablized with 0.2% Triton X-100 PBS(−), blocked
with broking buffer, incubated with anti-BrdU antibody
for 2 to 12 hours. After staining with the primary anti-
body, cells were washed with PBS(−), stained with anti-
mouse IgG1-Alexa488, washed with PBS(−) and moun-
ted on slide glass with Dako mounting buffer. Myoblasts
were fixed in 4% PFA/PBS (−) for 5 minutes, blocked
with 10% goat serum/PBS (−) for 10 minutes, and
stained with MyHC slow, MyHC fast, MyHC pan, anti-
mouse IgG1-Alexa568, anti-mouseIgG2b-Alexa648 (Life
Technologies) and DAPI (Sigma). Slides were mounted
in SlowFade Light antifade Kit Component A (Molecular
Probes) and analyzed with a Bio-Rad confocal laser scan-
ning microscope (model MRC-1024) (Bio-Rad Labora-
tories, Hercules, CA, USA).
ALP, X-gal and NADH-TR staining
Cells were fixed 2% PFA and washed with PBS(−), then
stained by alkaline phosphatase (ALP) buffer (100 mM
Tris–HCl pH 9.5, 100 mM NaCl, 50 mM MgCl2)
containing 4.5 μl nitro-blue tetrazolium chloride (NBT)
and 3.5 μl 5-bromo-4-chloro-3-indolyl phosphate (BCIP)
per 1 ml of ALP buffer at 37°C. Isolated whole embryos
and tissue were fixed in 2% PFA for 3 hours at 4°C and
permeablized with X-gal staining buffer (0.1 M phoshate
buffer (pH 7.3), 2 mM MgCl2, 0.01% sodium deoxy-
cholate, 0.02% Nonidet P-40) for 2 hours at 37°C and
stained by X-gal staining buffer with 0.1% X-gal, 5 mM
potassium ferricyanide and 5 mM potassium ferrocya-
nide at 37°C for 2 to 24 hours.
The isolated muscle tissues were placed directly into
optimal cutting temperature (OCT) compound and fro-
zen in deep cold isopentane with ethanol and dry ice.
The muscle tissues were cut 16 μm by cryostat and dried
in room temperature. The muscle sections were incu-
bated with NADH-TR staining solution (0.8 mg/ml
NADH and 1 mg/ml NBT in 50 mM Tris–HCl (pH 7.6)
at 37°C. The stained muscle sections were washed with
deionized water, unbound NBT was removed by acetone
solution, then the sections were re-washed with deio-
nized water and mounted with a coverslip.
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Myoblasts in 24-well plates were transfected with the plas-
mids indicated and 50 ng pRL-PGK using Lipofectamine
(Invitrogen). Transfected cells were harvested around 24
hours after transfection, and luciferase activities in the cell
extracts were measured according to the manufacturer's
instructions (Promega, Fitcburg, WI, USA) in a lumino-
meter (Microplate luminometer LB96V (EG&G Berthold
Technologies, Bad Wildbad, Germany). Luciferase acti-
vities as indicated by arbitrary unit were normalized by
sea urchin luciferase activities in each sample. All experi-
ments were repeated at least three times, and the averages
of more than three independent experiments with stan-
dard deviations are shown as bars [35].
Western blots
Infected C2C12 cells were grown in 60-mm dishes,
washed twice with PBS and lysed in 100 mL radioim-
munoprecipitation assay (RIPA) buffer (50 mM Tris HCl,
pH 7.5; 150 mM NaCl; 0.5% Nonidet P-40; 0.1%
deoxycholate) containing protease inhibitor cocktail
(Roche Applied Science, Penzberg, Germany) [35]. Cell
extracts were collected and spun in a microcentrifuge at
13,000 rpm for 5 minutes. Total proteins (5 mg) were sep-
arated on 10% SDS-PAGE and transferred to Immobilon-
P (EMD Millipore Corporation, Billerica, MA, USA). The
membranes were probed with primary antibodies, fol-
lowed by horseradish peroxidase (HRP)-conjugated se-
condary antibodies at 1:5,000 (Bio-Rad Laboratories), and
developed using ECL™ Plus (GE Healthcare, Chalfont St.
Giles, United Kingdam). Membranes were exposed to
BIOMAX film (Eastman Kodak, Rochester, NY, USA). Pri-
mary antibodies used in this work: anti-MyoD (5.8A, BD
Bioscience [San Jose, CA, USA]), anti-myogenin (F5D,
DSHB), anti-MHC (MF-20, DSHB), anti-GAPDH (6C5,
Life Technologies) and anti-.alpha;-tublin (Sigma-Aldrich).
Results
Canonical Wnt signaling is activated during fetal
myogenesis and reduced in adult muscle
As the first step to investigate the function of Wnt sig-
naling in myogenesis, we used the TCF-lacZ transgenic
reporter mouse to examine the activity of the canonical
Wnt signaling pathway in embryonic and adult muscles.
The promoter of the LacZ transgene (encoding β-
galactosidase, β-gal) contains multimerized TCF binding
sites [33], a key downstream effector of canonical Wnt
signaling. We analyzed β-gal activity, in embryonic and
adult muscles by X-GAL staining (Figure 1). β-gal activ-
ity was detected in many muscles in E14.5 embryos
(Figure 1A). Among those labeled, β-gal activity was par-
ticularly intense in both forelimb and hind limb muscles
(Figure 1B), ventral body wall muscles (Figure 1C), dor-
sal spinotrapezius (Figure 1D) and intercostal muscles.The number of muscles labeled with X-GAL was re-
duced in the forelimb and hand limb in P0 fetus
(Figure 1E, F). In the adult, β-gal activity was undetect-
able in EDL and TA, muscles that are predominantly
enriched with fast type myofibers, but was readily
detected in part of the diaphragm (Figure 1G) and soleus
(Figure 1H), muscles that are known to be enriched with
slow myofibers. These data indicate that canonical Wnt
signaling is strongly activated during fetal myogenesis
and declined in postnatal muscles with some residual ac-
tivity in slow myofibers.
Interestingly, the β-gal activity in postnatal slow
muscle was especially strong at neuromuscular junctions
(dark dotted staining patterns in the mid-belly of the
muscles; Figure 1G-H). To further examine this
phenomenon, we isolated single myofiber from the so-
leus muscles (containing about 50% slow and 50% fast
myofibers) of Tcf-lacZ mice. The isolated single
myofibers were fixed and stained with α-bungarotoxin
(BTX) and β-gal antibodies, together with slow-MyHC
or pan-MyHC antibodies (Figure 2A-D). Consistently,
strong β-gal immunoreactivity was detected proximal to
motor endplates located within BTX stained neuromus-
cular junctions of type I fibers (Figure 2A, B), but not in
type II myofibers (Figure 2C-D). Co-labeling whole
mount muscle with slow and fast myosin heavy antibody
confirmed the specific activation of β-gal in the in slow
myofibers (Figure 2E, F). Overall, 97% of the β-gal+
myofibers co-expressed the slow MyHC, where only 8%
of the β-gal- myofibers co-expressed slow MyHC (Figure
2G). These data indicate that canonical Wnt signaling is
highly activated at the neuromuscular junction area spe-
cifically in slow myofibers of adult skeletal muscles.
Canonical Wnt signaling promotes formation of slow
myofibers in vivo
To confirm the role of canonical Wnt signaling in
muscle fiber type specification in vivo, we took advan-
tage of the Ctnnblox(ex3) transgenic mice in which the
exon 3 of β-catenin (Ctnnb) gene flanked by LoxP sites
[34]. The exon 3 encodes serine and threonine residues
that are normally phosphorylated GSK3β, leading to the
proteasomal degradation of β-catenin. Upon Cre-
mediated excision of Ctnnb exon 3, β-cateninΔEx3 is
prevented from degradation (stabilized) and, therefore,
constitutively active.
We first used Myf5-Cre to induce β-cateninΔEx3 expres-
sion in myogenic progenitor cells. Myf5 is an early myo-
genic commitment marker during embryonic myogenesis
[36]. Myf5-Cre/Ctnnblox(ex3) mice die at E15.5 with
extremely reduced muscle mass (data not shown), thus
precluding further analysis of myofiber types. We next
used MCK-Cre to drive β-cateninΔEx3 expression only in
differentiated muscle cells. As expected, we detected
Figure 1 Activation of canonical Wnt signaling in embryonic, neonatal and adult skeletal muscles. Tcf-lacZ reporter mice were used to
report activation of TCF promoter, the nuclear target of canonical Wnt signaling. X-gal staining (in blue) was used to reveal LacZ (b-gal) activity.
(A) Whole mount staining of an E14.5 embryo. (B) Forelimbs and hind limbs at E14.5. (C) Ventral and (D) dorsal view of an E14.5 embryo
revealing intensive staining in some muscles. (E) Hind limb and (F) forelimb at P0 (postnatal Day 0). (G) Diaphragm and (H) soleus muscles of
adult mouse showing staining in a subset of myofibers with intensive signals at the neuromuscular junction area.
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transgenic mice carrying MCK-Cre, Ctnnblox(ex3) and TCF-
LacZ alleles. β-gal activity was detectable in TA muscles of
the MCK-Cre/Ctnnblox(ex3)/TCF-LacZ mice, but not the
Ctnnblox(ex3) /Tcf-lacZ littermate controls (Figure 3A, B).
In addition, we analyzed the oxidative activity of skeletal
muscle myofibers using NADH-tetrazolium (NADH-TR)
staining. Strikingly, the high and middle oxidative
myofibers were increased in TA muscles of MCK-Cre/
Ctnnblox(ex3) mice (n = 3, 65.4 ± 8.4% and 34.6 ± 8.4%, re-
spectively) compared to the same muscle of wild type lit-
termates (n = 3, 52.7 ± 5.3% and 19.0 ± 3.8%, respectively)
(Figure 3C-E). By contrast, the number of the lowoxidative myofibers was increased in wild type TA muscles
(n = 3, 28.3 ± 7.7%) compared relative to the mutant litter-
mate (Figure 3C-E). As slow muscles are known to con-
tain mainly oxidative myofibers and fast muscles are
mainly low oxidative and glycolytic [19], these data pro-
vide in vivo evidence that canonical Wnt signaling pro-
motes slow myofiber phenotype in the postnatal skeletal
muscle.
Canonical Wnt signaling inhibits proliferation of C2C12
and primary myoblasts
To identify the Wnt molecules that activate the canon-
ical Wnt signaling pathway in muscle, we co-transfected
Figure 2 Activation of canonical Wnt signaling in adult slow myofibers. (A-D) Soleus myofibers from adult Tcf-lacZ mice were stained with
antibodies for pan-myosin heavy chain (White) or slow myosin heavy chain (White), and β-gal (Red) and FITC conjugated BTX (Green). (E-F)
Whole mount muscles co-stained with antibodies for slow (Blue) and fast (Red) myosin heavy together with beta-gal (Green) and BTX (Red). (G)
Percentage of β-gal positive (n = 69) and negative (n = 60) myofibers that co-express slow myosin heavy chain.
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TopFlash. We found that Wnt-1 and Wnt-3a strongly ac-
tivated (>400 times increase in luciferase activity), Wnt-2
and Wnt-10b moderately activated (>20 times increase in
luciferase activity), and Wnt-2b and Wnt-4 weakly acti-
vated (>2 times increase in luciferase activity) the canon-
ical Wnt reporter (Additional file 2: Figure S1A). Other
Wnts (Wnt-5a, Wnt-5b, Wnt-6, Wnt-7a, Wnt-7b, Wnt-
10a, Wnt-11) had no effect on the activation of the Super
TopFlash reporter (Additional file 2, Figure S1A). We,
therefore, used Wnt-1 and Wnt-3a to activate the canon-
ical Wnt signaling in the following studies.We next examined the function of both canonical and
non-canonical Wnt signaling in cultured C2C12 myo-
blasts using retrovirus expressing various Wnts. Com-
pared to mock controls, C2C12 cells overexpressing
canonical Wnts (Wnt-1, -2, -2b, -3a, -10b) had a signifi-
cantly decreased cell number after 96 h in culture
(Additional file 2: Figure S1B). By contrast, C2C12 cells
overexpressing non-canonical Wnts (Wnt-5a, -5b, -6, -7b,
-11) had a moderately increased cell number compared to
the control treated cells (Additional file 2: Figure S1B).
A reduced cell number in C2C12 cells overexpressing
Wnt-1, -2, -2b, -3a and -10b indicates that canonical
Figure 3 Muscle-specific constitutive activation of canonical
Wnt signaling promotes oxidative myofiber phenotype. The
MCK-Cre/Ctnnblox(ex3) mice were used to express constitutively
active β-cateninΔex3, which mimics canonical Wnt signaling. The
MCK promoter-drive Cre expression limits Wnt activation only in
mature skeletal muscles. (A-B) X-Gal staining (blue signal) of whole
mount TA muscles of Ctnnblox(ex3)/Tcf-LacZ (WT) and MCK-Cre
/Ctnnblox(ex3)/Tcf-LacZ (Mut) mice. Blue signal, indicative of canonical
Wnt signaling, is only detectable in the Mut TA muscles (A and B
represent the dorsal and ventral view of the same muscles). (C-D)
NADH-TR staining of TA muscle sections from the WT (C) and Mut
(D) mice. (E) Percentage of high oxidative (black), middle oxidative (gray)
and low oxidative (white) myofibers of WT and Mut mice (n = 3, each).
Scale bar: 1 mm.
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we analyzed the expression of Ki-67 (Additional file 2:
Figure S1 C-E), a nuclear antigen specifically expressed
in S, G2 and M phase cells. The Wnt-1 and -3a ex-
pressing C2C12 cells had decreased Ki-67 expression
(Additional file 2: Figures S1 D-E, and 4I). In addition,
we examined incorporation of BrdU, a thymidine analog
that is incorporated into proliferating cells during the S
phase. Proliferating C2C12 cells were incubated with
BrdU for one hour and then fixed for BrdU staining
(Additional file 2: Figure S1F-H). Consistently, BrdU in-
corporation was reduced in the Wnt-1 and -3a express-
ing C2C12 cells (Additional file 2: Figure S1G-H, J).
Furthermore, we analyzed proliferation of skeletal
muscle-derived primary myoblasts cultured with recom-
binant Wnt-3a protein (50 ng/ml) for 24 hours. Both Ki-
67 expression (Additional file 3: Figure S2A-C) and
BrdU uptake (Additional file 3: Figure S2D-F) weredecreased in the presence of Wnt-3a protein. These re-
sults indicate that canonical Wnt signaling suppressed
the proliferation of C2C12 cells and adult primary
myoblasts.
To test if Wnt signaling has any effect on myogenic
differentiation, we induced C2C12 myoblasts to differen-
tiate. Upon serum withdrawal, control myoblasts exited
the cell cycle and fused to form myotubes with uniform
morphology (Additional file 4: Figure S3A). By contrast,
Wnt-1 and Wnt-3a expressing C2C12 cells formed very
few myosin heavy chain (MyHC) positive myotubes
(Additional file 4: Figure S3B-C). In addition, these
myotubes were morphologically abnormal: they were
short and chubby (Additional file 4: Figure S3B-C). As
previously reported, non-canonical Wnt7a overexpres-
sion led to the formation of large myotubes resembling
the muscle hypertrophy phenotype (Additional file 4:
Figure S3D). We further examined by Western blotting
the expression of two myogenic differentiation markers,
myogenin and MyHC. Compared to the control, Wnt-1
and -3a robustly inhibited the expression of Myogenin
and MyHC at 48 hours, 72 hours and 96 hours post-
induction of differentiation (Additional file 4: Figure
S3E). Intriguingly, the non-canonical Wnt-7a not only
increased Myogenin and MyHC protein levels, but also
induced their earlier expression at 24 hours (Additional
file 4: Figure S3E). However, recombinant Wnt-3a pro-
tein at 50 ng/ml had no effect on the differentiation of
neither C2C12 myoblasts (not shown) nor fetal primary
myoblasts (see Figure 4H). Thus, these data indicate that
prolonged high-level constitutive activation of Wnt-1
and Wnt-3a in C2C12 cells suppresses myogenic
differentiation.
Canonical Wnt signaling activates BMP signaling in C2C12
myoblasts
The reduced myogenic differentiation of Wnt-1 and
Wnt-3a overexpressing C2C12 myoblasts prompted us
to analyze the alternative differentiation fate of these
cells. Previous studies show that C2C12 cells can also
differentiate into osteogenic lineage [37], which express
ALP. Surprisingly, Wnt-1, Wnt-3a and Wnt-10b overex-
pression strongly induced ALP immunochemical signals
(Additional file 5: Figure S4A-F). By contrast, expression
of non-canonical Wnt-5a and Wnt-7a did not affect
ALP expression (Additional file 5: Figure S4D-E). Quan-
titative analysis confirms that Wnt-1 and Wnt-3a
increased ALP enzyme activity by 15- and 30-fold, re-
spectively (Additional file 5: Figure S4G).
To examine if Wnt-induced ALP activity was depen-
dent on β-catenin, which mediates canonical Wnt sig-
naling, we transduced C2C12 cells with a dominant
negative TCF-4b (DN-TCF-4b) that lacks the β-catenin
binding site. As expected, DN-TCF-4b suppressed both
Figure 4 Canonical Wnt signaling induces BMP-4 in C2C12 myoblasts. (A) qPCR analysis of the relative expression of various genes in C2C12
myoblasts overexpressing Wnt-1 and Wnt-3a under growth condition. (B) BMP-4 knockdown reduced the expression of alkaline phosphatase
(Akp2) but not the Axin2 gene. (C-F) BMP-4 shRNA rescued the myogenic differentiation of Wnt-1 and Wnt-3a infected C2C12 cells. (C-D) Wnt-1
and Wnt-3a overexpressing myoblasts treated with Scramble shRNA; (E-F) Wnt-1 and Wnt-3a overexpressing myoblasts treated with BMP-4 shRNA.
Black signaling is myosin heavy chain antibody staining reacted with 3, 3'-diaminobenzidine (DAB) substrate. (G) Western blotting showing
myosin heavy chain protein expression after BMP-4 shRNA treatment. (H) qPCR analysis of myosin heavy chain gene expression. (I-L) BMP-4
antagonist Noggin-Fc dose-dependently rescued the myogenic differentiation of Wnt-3a infected C2C12 cells. The myosin heavy chain was
labeled in black and nuclei were labeled in white.
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(Additional file 5: Figure S4H). These data indicate that
canonical Wnt signaling induces ALP expression via a
β-catenin/TCF-dependent pathway in C2C12 cells.
That canonical Wnt signaling induces osteogenic ALP
expression suggests a potential interaction between Wnt
and BMP signaling pathways. We first examined BMP-4
gene expression using quantitative RT-PCR (qPCR)
given its role in osteogenesis. Indeed, BMP-4 mRNAexpression was increased by more than five-fold in Wnt-
1 and Wnt-3a overexpressing C2C12 cells (Figure 4A).
In comparison, Myf5 and MyoD expression was not af-
fected by Wnt-1 and Wnt-3a (Figure 4A). To ensure that
canonical Wnt signaling is involved in the induction of
BMP-4, we examined Axin2, a transcriptional target of
β-catenin and canonical Wnt signaling [38]. Wnt-1 and
Wnt-3a overexpression led to over 40X increase in the
expression Axin2 (Figure 4A).
Figure 5 Wnt-3a induces slow myosin heavy chain expression in fetal myoblasts via BMP-4. Fetal myoblasts were isolated by fluorescence-
activated cell sorting (FACS) from E14.5-15.5 embryos of Myf5-Cre/Rosa26-YFP mice. FACS isolated fetal myoblasts were cultured and induced to
differentiate for three days. (A-D) Immunofluorescence showing slow myosin heavy chain (green) expression in myotubes treated with vehicle
control medium or Wnt-3a recombinant protein (50 ng/ml). (E) Relative expression of myosin heavy chain and BMP-4 genes based on qPCR
analysis. (F) Western blotting showing slow myosin heavy chain protein expression. (G-J) Immunofluorescence showing slow- (green) and pan-
(red) myosin heavy chain expression in myotubes treated with vehicle control medium, Wnt-3a, and BMP-4 recombinant protein at concentration
shown. (K) qPCR analysis showing relative expression of myosin heavy chain isoform genes. Scale bars: 40 μm.
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osteogenic effect of canonical Wnt signaling. We used
lentiviral shRNA mediated knockdown of BMP-4 in
C2C12 cells. This approach resulted in nearly 80% reduc-
tion of BMP-4 transcripts (Figure 4B). Importantly, BMP-
4 knockdown reduced Wnt-1 and Wnt-3a induced Akp4
(ALP gene) expression by more than 70% (Figure 4B). By
contrast, Axin2 mRNA levels were not decreased follow-
ing knockdown of BMP-4 (Figure 4B), suggesting that
BMP-4 signaling does not affect canonical Wnt signaling.
We further investigated if the anti-myogenic effect of ca-
nonical Wnt signaling is mediated by BMP-4 using the
same shRNA knockdown approach. In the control groups
(scrambled shRNA), there were only a few MyHC positivemyotubes in the C2C12 cells overexpressing Wnt-1
(Figure 4C) and Wnt-3a (Figure 4C). Knockdown of BMP-
4 remarkably increased the numbers of MyHC positive
myotubes in Wnt-1 (Figure 4E) and Wnt-3a (Figure 4F)
expressing C2C12 cells. Consistent with this observation,
BMP-4 shRNA rescued MyHC protein expression in Wnt-
1 and Wnt-3a overexpressing C2C12 cells (Figure 4G).
Moreover, BMP-4 shRNA increased the mRNA levels of
Myogenin, MyHC-IIa, MyHC-IIb and MyHC-I (Figure 4H).
To confirm the above observations, we used recombinant
Noggin protein, an antagonist of BMP, to block BMP activ-
ity. Noggin dose-dependently increased the number of
MyHC positive myotubes in Wnt-3a expressing C2C12
cells (Figure 4I-L). These data provide compelling evidence
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tiation through inducing BMP-4 signaling.Canonical Wnt signaling induces slow MyHC expression
through BMP-4
To directly examine the function of canonical Wnt signa-
ling in muscle fiber type specification, we isolated em-
bryonic myoblasts from E14.5 embryos by FACS. We
employed positive selection for Myf5 and α7-integrin ex-
pression of myogenic cells from Myf5-Cre/ROSA-YFP em-
bryos (Additional file 6: Figure S5). The purity of isolated
fetal myoblasts was confirmed by immunostaining for
Pax7 and desmin (Additional file 6: Figure S5). Embryonic
myoblasts were cultured for one day before being induced
to differentiate with or without the addition of Wnt-3a
protein (50 ng/ml). In the absence of Wnt-3a, embryonic
myoblasts differentiated into myotubes that expressed fast
MyHC (Figure 5A), but not slow MyHC (Figure 5C) in
agreement with previous studies [39]. By contrast, Wnt-3a
treated fetal myoblasts differentiated into myotubes
that expressed both fast (Figure 5B) and slow MyHC
(Figure 5D).
To confirm this result, we analyzed MyHC-I mRNA
expression by qPCR. The MyHC-I mRNA level was up-
regulated 5.5-fold by Wnt-3a compared to control ve-
hicle treatment (Figure 5E). Wnt3a also robustly induced
the expression of slow MyHC-I at the protein level
(Figure 5F). These results indicate that canonical Wnt
signaling induces slow MyHC expression in fetal
myoblasts.
As canonical Wnt signaling induced BMP-4, we fur-
ther examined the role of BMP-4 in muscle fiber type
specification. Consistent with our previous results in
C2C12 cells (Figure 4A), Wnt-3a treatment of embry-
onic myoblasts induced a seven-fold increase in BMP-4
mRNA expression (Figure 5E). Next, we added recom-
binant BMP-4 to fetal myoblast cultures during
differentiation. In the control treated with vehicle
medium, newly formed MyHC+ myotubes seldom
expressed slow MyHC after three days of differentia
tion (Figure 5G). In the presence of 2.5 to 5 ng/ml
BMP-4, slow-MyHC+ myotubes were abundantly visible
(Figure 5I-J). The level of slow MyHC immunofluores-
cence induced by 5 ng/ml BMP-4 is similar to that in-
duced by 50 ng/ml Wnt-3a (Figure 5H), suggesting
BMP-4 more potently induces slow MyHC expression.
Western blotting showed that the slow MyHC protein
expression level was indeed increased in the presence of
BMP-4 (Figure 5F). In addition, qPCR analysis indicated
that BMP-4 not only induced the slow MyHC-I gene ex-
pression, but also robustly suppressed the fast MyHC-IIb
gene expression (Figure 5K). Collectively, these results
indicate that canonical Wnt signaling acts throughBMP-4 to induce slow MyHC expression during embry-
onic myoblast differentiation.
Discussion
In this study, we use genetic, cell culture and molecular
biology approaches to dissect the function of canonical
Wnt signaling in myogenic differentiation and skeletal
myofiber types. We show that the canonical Wnt signal-
ing is most active during perinatal myogenesis and only
activated in slow myofibers with high activity at the
neuromuscular junction area in mature muscles. Con-
stitutive activation of β-catenin, the canonical Wnt sig-
naling effector, leads to impaired myogenesis and an
increased proportion of oxidative myofibers in the post-
natal muscles. Importantly, Wnt-1 and Wnt-3a mediated
downstream signaling activates BMP-4, which inhibits
the overall proliferation of myoblasts and promotes
myogenic differentiation towards slow muscle pheno-
type. These results establish a novel interaction between
Wnt and BMP signaling that regulates muscle fiber type
specification and maintenance.
The TCF-LacZ reporter mouse has been widely used
in reporting activation of canonical Wnt signaling in
various tissues/cells [11,40]. Strong LacZ expression in
specific muscles during embryonic and fetal myogenesis
indicates activation of canonical Wnt signaling. Interes-
ting, several muscles (spinotrapezius, body wall muscle
and diaphragm) with high β-gal activity are known to be
enriched with slow myofibers [19]. These results suggest
a role of Wnt signaling in slow muscle generation and
maintenance. Our in vivo results are consistent with pre-
vious studies in chick and fish embryos, in which cano-
nical Wnt signaling was shown to promote slow muscle
fate [20-22].
Our analysis of canonical Wnt signaling in adult ma-
ture muscles reveal several interesting points. First, β-gal
activity is only detectable in muscles known to contain
slow myofibers. This result confirms our observation in
the developing embryonic muscles. Second, in contrast
to embryonic muscle, where β-gal activity is evenly dis-
tributed within myofibers, the highest β-gal activity was
within the slow myofibers was proximal to the motor
endplate (Figure 1G-H). This observation suggests that
whereas in embryonic muscle the Wnt molecules are
released from surrounding tissues [5], Wnt signaling
in adult slow myofibers is most likely initiated by Wnt
molecules from motor neurons that innervate these
myofibers. In support of the notion that the motor
neuron supplies Wnt molecules, we found that β-gal
immunoreactivity was no longer detectable in slow
myofibers after three days of suspended culture in vitro
in the absence of neural innervation (data not shown).
Previous studies demonstrate that Wnt molecules
released by motor neurons play key roles in the
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interaction of Wnt and LRP is necessary for clustering
of postsynaptic acetylcholine receptors (AchR) [24]. Our
new results demonstrate that Wnt signaling is further
required for the maintenance of neuromuscular junction
in slow myofibers. Future study is needed to examine
the functional significance of Wnt signaling in slow ver-
sus fast muscle fibers and identify the Wnt molecules re-
leased by slow and fast motor neurons.
Using Cre-inducible transgenic mice that express sta-
bilizes β-catenin, we investigated the role of canonical
Wnt signaling in embryonic myogenesis and postnatal
muscle maintenance. When Myf5-Cre is used as the
driver mouse, which is expressed in embryonic myogenic
progenitors, we detected abnormal muscle development
and perinatal lethality. This observation is consistent to
recent studies using Pax7-Cre or Myogenin-Cre to
stabilize β-catenin, which also results in lethality at P0
[23,41]. In these studies, constitutive activation of β-
catenin in the myogenic progenitors and committed
myocytes resulted in a shift of fetal myofibers to slow
muscle phenotype, and reduced myofiber size. However,
the perinatal lethality of the Myf5-Cre, Myogenin-Cre and
Pax7-Cre drive β-catenin activation precludes analysis of
postnatal muscles. Using the Mck-Cre/ctnnbLox(ex3) mice,
we found that adult muscles indeed have higher canonical
Wnt activity based on the TCF-LacZ reporter assay. This
verifies the utility of our mouse model.
Importantly, we found the adult fast (TA) muscles
exhibited features of slow muscle phenotype as increased
oxidative capacity. We also examined myosin heavy
chain expression by immunohistochemistry but did not
find any overt changes in myofiber types (data not
shown). This result suggests that although Wnt signaling
affects metabolic properties in the adult muscles, it is
not sufficient to switch myosin heavy chain expression
in the adult. This is expected since other factors, such as
hormones and neural activity, can also influence myosin
expression [19]. Together, our Mck-Cre/ctnnbLox(ex3) mo-
del bypasses the premature lethality and provides novel
insights of canonical Wnt signaling in regulating the oxi-
dative capacity of adult muscles.
The observation that C2C12 cells overexpressing Wnt-1
and Wnt-3a exhibited reduced proliferation and myo-
genic differentiation is quite intriguing. It could suggest
that canonical Wnt/β-catenin inhibits the proliferation
and differentiation of myogenic cell lineages. This pos-
sibility would explain the reduced muscle mass phe-
notypes of the Myf5-Cre, Myogenin-Cre and Pax7-Cre
induced stabilized β-catenin mice [23,41]. Alternati-
vely, the result may also suggest that expression of
Wnt-1 and Wnt-3a in the cell, independent of Frizzled
receptor activation, is detrimental to cell growth and
differentiation.Interestingly, embryonic and fetal myoblasts seem to
have different responses to canonical Wnt signaling [23],
suggesting that the role of Wnt signaling, even in the
same cell lineage, is also context dependent. Consistent
with this notion, we show that the growth and differenti-
ation of fetal primary myoblasts are not inhibited by re-
combinant Wnt-3a protein in culture. The osteogenic
fate choice of Wnt-1 and Wnt-3a overexpressing C2C12
cells is in line with a recent report demonstrating fibro-
blastic lineage differentiation of satellite cells in response
to high level of systemic Wnt molecules [18]. Thus, the
observed effect of Wnt-1 and Wnt-3 in myogenic cell
proliferation and differentiation is largely consistent with
information in the literature.
We discovered a novel interaction between Wnt and
BMP signaling in myoblasts. Bone morphogenetic pro-
teins (BMPs) are multi-functional proteins belonging to
the transforming growth factor beta (TGFβ) superfamily.
In zebrafish and frogs, BMP signaling inhibits the diffe-
rentiation of muscle precursors in the dermomyotome
and controls the number of myogenic cells [42,43]. Du-
ring late myogenesis of mice, BMP signaling regulates the
number of fetal myoblasts and satellite cells [44]. This ac-
tion is through preventing the premature activation of
MyoD while maintaining Pax3 expression. Therefore,
BMPs may function to establish a sufficient number of
myogenic progenitors before terminal differentiation.
Our cell culture results indicate that Wnt signaling in-
duces BMP4, and BMP4 inhibition rescues the inhibitory
effect of Wnt-1 and Wnt-3a on myogenesis. This result is
in line with the above results in vivo. We further identify
an unexpected role for BMP-4 in promoting slow muscle
fate during fetal myogenesis. It is important to mention
that low concentrations (1 to 5 ng/ml) of BMP-4 protein
were used in our study. Non-physiological, high concen-
trations of BMP will probably generate completely diffe-
rent effects [45]. Future studies should illustrate how BMP
signaling regulates myosin gene expression.
Interestingly, in Drosophila larval neuromuscular junc-
tions, retrograde BMP signaling controls synaptic growth
[46]. The muscle-derived BMP modulates cytoskeletal dy-
namics and structural changes at presynaptic terminals.
This forms a feedback system in which canonical Wnt
molecules secreted from motor neurons not only induce
formation of neuromuscular junctions, but also activate
BMP-4 expression in the muscle. The muscle derived
BMP-4 subsequently promotes development of presynaptic
motor neuron terminals. Indeed, β-catenin stabilization in
skeletal muscles (not limited to the neuromuscular junc-
tion area) results in increased motor axon number and ex-
cessive intramuscular nerve defasciculation and branching
[41]. Taken together, our experiments have identified a
novel interaction between canonical Wnt and BMP signa-
ling that plays a role in myofiber type specification.
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Our study demonstrates that canonical Wnt-signaling
controls the development of skeletal muscles via BMP-4
expression. High concentrations of BMP-4 have been
previously established to inhibit myogensis and induce
osteogenesis. We found that isolated fetal myoblasts do
not normally form slow myofibers during myogenic dif-
ferentiation in vitro. Strikingly, canonical Wnt-signaling
induced low level BMP-4 expression that act to induce
slow myofibergenesis. Therefore, we conclude that ca-
nonical Wnt and BMP signaling plays a hitherto un-
appreciated role in myofiber type specification during
fetal myogenesis.
Additional files
Additional file 1: Table S1. The sequence of PCR primers for qPCR
analysis is listed.
Additional file 2: Figure S1. Canonical Wnt signaling inhibits the
growth and proliferation of C2C12 myoblast cells. (A) Relative luciferase
activity of C2C12 cells overexpressing various Wnt genes together with
the SuperTop Flash reporter plasmid. (B) Graph of C2C12 cells transduced
with retroviral Wnt plasmids. (C-E) The Ki-67 antibody staining and (F-H)
BrdU incorporation of control, Wnt-1 and Wnt-3a transduced cells. (I)
Percentage of Ki-67 positive cells in control, Wnt-1 and Wnt-3a
transduced cells. (J) Percentage of BrdU incorporated cells in Control,
Wnt-1 and Wnt-3a retrovirus infected C2C12 cells.
Additional file 3: Figure S2. Wnt-3a inhibits proliferation of adult
primary myoblasts. (A-B) Ki-67 antibody staining of primary myoblasts
treated with vehicle control (A) and Wnt-3a recombinant protein (50 ng/
ml) (B). (C) Percentage of Ki67 positive cells. (D-E) BrdU incorporation of
primary myoblast cells treated with control (D) and Wnt-3a protein (E). (F)
Percentage of cells incorporated BrdU.
Additional file 4: Figure S3. Overexpression of Wnt-1 and Wnt-3a
inhibits the myogenic differentiation of C2C12 myoblasts. (A-D)
Immunofluorescence showing sarcomeric myosin heavy chain protein
expression in C2C12 cells transduced with retrovirus overexpressing (A)
Mock, (B) Wnt-1, (C) Wnt-3a and (D) Wnt-7a after four days of induced
myogenic differentiation. (E) Western blotting analysis showing
expression of myosin heavy chain (MyHC), myogenin and GAPDH in
control, Wnt-1, Wnt-3a and Wnt-7a overexpression C2C12 myoblasts at
different time points after induced to differentiate. GAPDH:
Glyceraldehyde 3-phosphate dehydrogenase. Scale bar: 100 μm.
Additional file 5: Figure S4. Canonical Wnts (−1, -3a and 10b) induces
alkaline phosphatase (ALP) activity in C2C12 cells. (A-F) ALP staining
(Purple signal) of C2C12 cells transduced retrovirus expressing empty
vector (Mock) or Wnt vectors as indicated. (G) Relative ALP activity. (H)
The dominant negative (DN) TCF-4 suppressed ALP activity in Wnt-1 and
Wnt-3a expressing C2C12 cells.
Additional file 6: Figure S5. Isolation of fetal myoblasts from E14.5
embryos of Myf5-Cre/ROSA26-YFP mice by fluorescence activated cell
sorting (FACS). (A-C) YFP expression in whole embryo (A), forelimb (B)
and hindlimb (C) of E14.5-15.5 Myf5-Cre/ROSA26-YFP embryo. (D)
Strategy for isolating fetal myoblasts by FACS. Whole limbs of Myf5-Cre
/ROSA26-YFP embryos were minced and digested by collagenase and
dispase. Single cells were stained with alpha7-integrin antibody and
selected by YFP and alpha7-integrin expression. The sorted YFP and
alpha7-integrin double positive cells were stained with antibody for Pax7
and desmin, makers of fetal myoblasts (nuclei were counterstained by
DAPI in blue).
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